Index S&P 500
P/E 4.96
EPS (ttm) 6.72
Insider Own 1.17%
Shs Outstand 497.52M
Perf Week -37.82%
Market Cap 16.58B
Forward P/E 4.17
EPS next Y 8.00
Insider Trans 0.00%
Shs Float 491.78M
Perf Month -39.84%
Enterprise Value -
PEG 0.57
EPS next Q 2.01
Inst Own 98.50%
Short Float 1.89%
Perf Quarter -45.15%
Income 3.45B
P/S 0.10
EPS this Y 1.95%
Inst Trans 1.02%
Short Ratio 1.40
Perf Half Y -44.81%
Sales 169.28B
P/B 0.59
EPS next Y 9.38%
ROA 4.07%
Short Interest 9.31M
Perf YTD -45.01%
Book/sh 56.11
P/C -
EPS next 5Y 8.64%
ROE 12.59%
52W High 80.59 -58.67%
Perf Year -49.02%
Cash/sh -
P/FCF 11.11
EPS past 3/5Y 40.38% 14.96%
ROIC 7.47%
52W Low 33.76 -1.33%
Perf 3Y -60.50%
Dividend Est. 1.00 (3.00%)
EV/EBITDA -
Sales past 3/5Y 8.98% 16.92%
Gross Margin -
Volatility 5.21% 2.80%
Perf 5Y -44.25%
Dividend TTM -
EV/Sales -
EPS Y/Y TTM 33.30%
Oper. Margin 2.14%
ATR (14) 2.90
Perf 10Y -18.24%
Dividend Ex-Date -
Quick Ratio -
Sales Y/Y TTM 8.85%
Profit Margin 2.04%
RSI (14) 15.68
Recom 2.23
Dividend Gr. 3/5Y - -
Current Ratio 1.11
EPS Q/Q 21.75%
SMA20 -36.72%
Beta 0.46
Target Price 65.88
Payout 0.00%
Debt/Eq 0.66
Sales Q/Q 15.38%
SMA50 -41.22%
Rel Volume 5.07
Prev Close 33.78
Employees 60500
LT Debt/Eq 0.66
Earnings Jul 25 BMO
SMA200 -45.41%
Avg Volume 6.65M
Price 33.31
IPO Dec 13, 2001
Option/Short Yes / Yes
EPS/Sales Surpr. 15.05% 9.03%
Trades
Volume 33,733,991
Change -1.39%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-02-25 Downgrade
UBS
Buy → Neutral
$45
Jul-02-25 Downgrade
JP Morgan
Overweight → Neutral
$48
Jun-09-25 Resumed
Morgan Stanley
Overweight
$70
Jun-02-25 Downgrade
Barclays
Overweight → Equal Weight
$65
Apr-08-25 Upgrade
Jefferies
Underperform → Hold
$64
Feb-06-25 Downgrade
Argus
Buy → Hold
Dec-17-24 Resumed
JP Morgan
Overweight
$80 → $75
Dec-13-24 Upgrade
UBS
Neutral → Buy
$79 → $80
Dec-10-24 Downgrade
Jefferies
Hold → Underperform
$68 → $52
Jul-24-24 Downgrade
Jefferies
Buy → Hold
$83 → $69
May-30-24 Initiated
Robert W. Baird
Neutral
$83
Mar-21-24 Downgrade
Stephens
Overweight → Equal-Weight
$92 → $85
Mar-06-24 Initiated
Barclays
Overweight
$101
Jan-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$82 → $90
Sep-05-23 Upgrade
BofA Securities
Underperform → Neutral
$79 → $72
Aug-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$94 → $73
Jul-12-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-20-23 Initiated
UBS
Neutral
$72
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$80
Mar-08-23 Downgrade
Deutsche Bank
Buy → Hold
$94 → $79
Show Previous Ratings
Today 09:59AM
Jul-03-25 04:47PM
09:50AM
08:32AM
05:22AM
04:52AM
Loading…
04:52AM
02:47AM
Jul-02-25 10:12PM
08:28PM
08:28PM
07:27PM
05:53PM
(The Wall Street Journal)
05:14PM
05:01PM
(The Wall Street Journal)
04:45PM
04:19PM
Loading…
04:19PM
(The Wall Street Journal)
04:14PM
02:49PM
02:23PM
02:15PM
12:45PM
12:22PM
11:34AM
11:15AM
10:27AM
10:14AM
10:09AM
09:51AM
09:50AM
09:40AM
09:32AM
Loading…
09:32AM
(The Wall Street Journal)
08:59AM
(Investor's Business Daily)
08:59AM
08:50AM
08:37AM
07:32AM
07:09AM
05:31AM
05:16AM
Jul-01-25 08:21PM
06:44PM
(The Wall Street Journal)
05:19PM
04:40PM
02:34PM
Jun-27-25 11:36AM
09:35AM
04:27AM
Jun-26-25 04:12PM
(Investor's Business Daily)
09:40AM
09:14AM
Jun-25-25 04:46PM
08:50AM
Jun-22-25 11:33PM
Jun-20-25 03:18PM
08:11AM
Jun-18-25 06:05AM
Jun-17-25 11:15AM
06:20AM
Jun-16-25 09:45AM
09:40AM
09:29AM
Jun-15-25 05:49AM
05:39AM
Jun-13-25 12:00PM
09:55AM
Jun-12-25 12:36AM
Jun-10-25 09:45AM
09:40AM
Jun-09-25 06:00AM
Jun-04-25 04:57AM
Jun-03-25 11:50AM
11:00AM
10:24AM
04:43AM
May-30-25 09:40AM
May-29-25 11:50PM
11:00AM
09:05AM
07:00AM
May-27-25 04:21PM
08:39AM
May-23-25 11:15AM
07:28AM
May-22-25 04:55PM
May-21-25 09:17AM
May-20-25 03:00PM
01:26PM
May-19-25 09:05AM
May-18-25 11:35PM
May-15-25 08:10PM
08:36AM
May-14-25 11:15AM
09:40AM
09:40AM
08:57AM
07:46AM
12:46AM
May-13-25 05:53PM
10:37AM
May-12-25 08:55AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
FASOLA KENNETH J Officer Mar 21 '25 Proposed Sale 59.06 8,500 501,970 Mar 21 10:37 AM Greco Thomas Director Dec 18 '24 Buy 59.75 17,000 1,015,750 19,309 Dec 19 05:39 PM Dallas H James Director Dec 16 '24 Buy 59.01 1,693 99,904 1,693 Dec 17 07:34 PM BLUME JESSICA L. Director Dec 16 '24 Buy 59.48 250 14,870 250 Dec 17 07:33 PM COUGHLIN CHRISTOPHER J Director Dec 16 '24 Buy 59.44 10,000 594,400 36,358 Dec 17 07:33 PM Samuels Theodore R. II Director Dec 13 '24 Buy 58.86 5,000 294,300 23,000 Dec 17 07:33 PM Asher Andrew Lynn Chief Financial Officer Nov 13 '24 Buy 58.14 17,200 1,000,008 486,847 Nov 13 06:07 PM LONDON SARAH Chief Executive Officer Nov 08 '24 Buy 60.80 4,117 250,314 667,229 Nov 08 06:15 PM